Tarsier Pharma

Tarsier Pharma company information, Employees & Contact Information

Updated June 2026

Quick answer

Tarsier Pharma is a Pharmaceutical Manufacturing company and founded in 2016. It has approximately 12 employees on record. Contact data was last refreshed in June 2026. Find Tarsier Pharma's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Tarsier® Pharma is a clinical late stage company developing novel treatments for ocular inflammatory blinding diseases, beginning with uveitis.

Company Details

Employees
12
Founded
2016
Address
Zichron Yaacov, Zichron Yaacov,israel 30900,israel
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Zichron Yaacov, Israel
Looking for a particular Tarsier Pharma employee's phone or email?

Tarsier Pharma Questions

News

Tarsier Pharma: New Data Reveal Sharp Rise in Vision Loss from Uveitis, Underscoring Urgent Need for Safer Treatments - PR Newswire

Tarsier Pharma: New Data Reveal Sharp Rise in Vision Loss from Uveitis, Underscoring Urgent Need for Safer Treatments PR Newswire

Tarsier Pharma holds Type C meeting with FDA for TRS01 in noninfectious uveitis - Ophthalmology Times

Tarsier Pharma holds Type C meeting with FDA for TRS01 in noninfectious uveitis Ophthalmology Times

Tarsier Pharma Receives FDA Agreement Under Special Protocol Assessment (SPA) for Tarsier-04 Phase 3 Trial of TRS01 Ophthalmic Solution for the Treatment of Non-infectious Uveitis including Uveitic Glaucoma - PR Newswire

Tarsier Pharma Receives FDA Agreement Under Special Protocol Assessment (SPA) for Tarsier-04 Phase 3 Trial of TRS01 Ophthalmic Solution for the Treatment of Non-infectious Uveitis including Uveitic Glaucoma PR Newswire

FDA, Tarsier Pharma Reach Agreement on Phase 3 Trial of TRS01 Eye Drops - HCPLive

FDA, Tarsier Pharma Reach Agreement on Phase 3 Trial of TRS01 Eye Drops HCPLive

Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer, Expanding Its U.S. Presence - PR Newswire

Tarsier Pharma Appoints Ashley Kline as Chief Commercial Officer, Expanding Its U.S. Presence PR Newswire

Tarsier Pharma shares results from phase 3 TRS4VISION trial - Ophthalmology Times

Tarsier Pharma shares results from phase 3 TRS4VISION trial Ophthalmology Times

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant